Accuray, Inc. (ARAY)
0.2798
-0.01
(-4.41%)
USD |
NASDAQ |
May 19, 16:00
0.285
+0.01
(+1.86%)
After-Hours: 20:00
Accuray Research and Development Expense (Quarterly) : 8.178M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| OraSure Technologies, Inc. | 13.30M |
| Insulet Corp. | 89.70M |
| Tandem Diabetes Care, Inc. | 46.04M |
| Abbott Laboratories | 767.00M |
| AngioDynamics, Inc. | 7.084M |